Sweden · Delayed Price · Currency is SEK BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of SEK 27.25 billion. The enterprise value is 25.41 billion.
| Market Cap | 27.25B |
| Enterprise Value | 25.41B |
Important Dates
The last earnings date was Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BioArctic AB has 88.58 million shares outstanding. The number of shares has increased by 0.60% in one year.
| Current Share Class | 74.24M |
| Shares Outstanding | 88.58M |
| Shares Change (YoY) | +0.60% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 30.74% |
| Owned by Institutions (%) | 47.76% |
| Float | 55.64M |
Valuation Ratios
The trailing PE ratio is 27.33 and the forward PE ratio is 123.78.
| PE Ratio | 27.33 |
| Forward PE | 123.78 |
| PS Ratio | 14.22 |
| PB Ratio | 13.84 |
| P/TBV Ratio | 13.84 |
| P/FCF Ratio | 25.61 |
| P/OCF Ratio | 24.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.58, with an EV/FCF ratio of 23.89.
| EV / Earnings | 25.42 |
| EV / Sales | 13.26 |
| EV / EBITDA | 19.58 |
| EV / EBIT | 19.79 |
| EV / FCF | 23.89 |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.18 |
| Quick Ratio | 3.14 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.04 |
| Interest Coverage | 40.41 |
Financial Efficiency
Return on equity (ROE) is 69.23% and return on invested capital (ROIC) is 53.68%.
| Return on Equity (ROE) | 69.23% |
| Return on Assets (ROA) | 43.46% |
| Return on Invested Capital (ROIC) | 53.68% |
| Return on Capital Employed (ROCE) | 64.18% |
| Revenue Per Employee | 15.71M |
| Profits Per Employee | 8.19M |
| Employee Count | 107 |
| Asset Turnover | 1.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioArctic AB has paid 172.92 million in taxes.
| Income Tax | 172.92M |
| Effective Tax Rate | 14.75% |
Stock Price Statistics
The stock price has increased by +68.27% in the last 52 weeks. The beta is -0.92, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.92 |
| 52-Week Price Change | +68.27% |
| 50-Day Moving Average | 293.62 |
| 200-Day Moving Average | 232.84 |
| Relative Strength Index (RSI) | 56.06 |
| Average Volume (20 Days) | 236,447 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of SEK 1.92 billion and earned 999.69 million in profits. Earnings per share was 11.25.
| Revenue | 1.92B |
| Gross Profit | 1.86B |
| Operating Income | 1.28B |
| Pretax Income | 1.17B |
| Net Income | 999.69M |
| EBITDA | n/a |
| EBIT | 1.28B |
| Earnings Per Share (EPS) | 11.25 |
Balance Sheet
The company has 1.88 billion in cash and 46.56 million in debt, giving a net cash position of 1.84 billion or 20.72 per share.
| Cash & Cash Equivalents | 1.88B |
| Total Debt | 46.56M |
| Net Cash | 1.84B |
| Net Cash Per Share | 20.72 |
| Equity (Book Value) | 1.97B |
| Book Value Per Share | 22.23 |
| Working Capital | 1.91B |
Cash Flow
In the last 12 months, operating cash flow was 1.09 billion and capital expenditures -26.64 million, giving a free cash flow of 1.06 billion.
| Operating Cash Flow | 1.09B |
| Capital Expenditures | -26.64M |
| Free Cash Flow | 1.06B |
| FCF Per Share | 12.01 |
Margins
Gross margin is 97.08%, with operating and profit margins of 67.02% and 52.17%.
| Gross Margin | 97.08% |
| Operating Margin | 67.02% |
| Pretax Margin | 61.19% |
| Profit Margin | 52.17% |
| EBITDA Margin | n/a |
| EBIT Margin | 67.02% |
| FCF Margin | 55.51% |
Dividends & Yields
BioArctic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.60% |
| Shareholder Yield | -0.60% |
| Earnings Yield | 3.67% |
| FCF Yield | 3.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |